Bicara Therapeutics Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.96 M | $121.17 M | 0.00% | 12.78% |
SIREN, L.L.C. | 02/14/2025 | 3.27 M | $57.01 M | 6.51% | 6.02% |
02/14/2025 | 3.17 M | $55.23 M | 100.00% | 5.83% | |
TPG GP A, LLC | 02/14/2025 | 3.01 M | $52.44 M | 0.00% | 5.53% |
OMEGA FUND MANAGEMENT, LLC | 02/14/2025 | 2.20 M | $38.41 M | 0.00% | 4.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.18 M | $37.89 M | 171.91% | 4.00% |
FMR LLC | 02/13/2025 | 2.12 M | $36.88 M | -6.89% | 3.89% |
BRAIDWELL LP | 02/14/2025 | 2.00 M | $34.85 M | 20.70% | 3.68% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 2.00 M | $34.84 M | 150.99% | 3.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 1.80 M | $31.27 M | 0.00% | 3.30% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 1.28 M | $22.37 M | 0.00% | 2.36% |
BLACKROCK, INC. | 02/07/2025 | 1.26 M | $21.98 M | 100.00% | 2.32% |
FIL LTD | 02/13/2025 | 1.01 M | $17.66 M | 0.00% | 1.86% |
FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 950,000 | $16.55 M | 100.00% | 1.75% |
BLACKSTONE INC. | 02/14/2025 | 913,060 | $15.91 M | 40.47% | 1.68% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 863,846 | $15.01 M | -27.30% | 1.59% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 833,333 | $14.52 M | 0.00% | 1.53% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 821,264 | $14.31 M | 16.00% | 1.51% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 757,968 | $13.20 M | -0.78% | 1.39% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 710,000 | $12.37 M | 67.06% | 1.30% |
02/14/2025 | 643,381 | $11.21 M | 100.00% | 1.18% | |
AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 568,919 | $9.91 M | 0.00% | 1.05% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 466,642 | $8.13 M | 859.40% | 0.86% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 445,975 | $7.77 M | 0.00% | 0.82% |
MORGAN STANLEY | 02/14/2025 | 402,918 | $7.02 M | 20,045.90% | 0.74% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 385,406 | $6.71 M | 28.66% | 0.71% |
FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 346,170 | $6.03 M | -38.45% | 0.64% |
ORBIMED ADVISORS LLC | 02/14/2025 | 298,301 | $5.20 M | 9.71% | 0.55% |
WOODLINE PARTNERS LP | 02/14/2025 | 275,692 | $4.80 M | -0.82% | 0.51% |
NORTHERN TRUST CORP | 02/14/2025 | 159,043 | $2.77 M | 100.00% | 0.29% |
02/14/2025 | 135,000 | $2.35 M | 100.00% | 0.25% | |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 105,500 | $1.84 M | 100.00% | 0.19% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 102,420 | $1.78 M | 0.00% | 0.19% |
NORGES BANK | 02/12/2025 | 70,000 | $1.22 M | 100.00% | 0.13% |
MARSHALL WACE, LLP | 02/13/2025 | 67,733 | $1.18 M | 100.00% | 0.12% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/10/2025 | 38,035 | $646,595 | 100.00% | 0.07% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 33,677 | $586,653 | 658.32% | 0.06% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 29,138 | $507,584 | 27.47% | 0.05% |
XTX TOPCO LTD | 02/13/2025 | 27,334 | $476,158 | 100.00% | 0.05% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 25,028 | $435,988 | 100.00% | 0.05% |
MAVEN SECURITIES LTD | 02/14/2025 | 25,000 | $435,500 | -50.00% | 0.05% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 21,630 | $376,795 | 100.00% | 0.04% |
WEXFORD CAPITAL LP | 02/14/2025 | 20,000 | $348,400 | 100.00% | 0.04% |
CINCTIVE CAPITAL MANAGEMENT LP | 02/12/2025 | 16,984 | $295,861 | 88.69% | 0.03% |
CITIGROUP INC | 02/12/2025 | 15,488 | $269,801 | 6,046.03% | 0.03% |
LMR PARTNERS LLP | 02/14/2025 | 15,150 | $263,913 | 100.00% | 0.03% |
CAXTON CORP | 02/14/2025 | 10,941 | $190,593 | 0.00% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 10,907 | $190,000 | 100.00% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 9,597 | $167,180 | 100.00% | 0.02% |
FEDERATED HERMES, INC. | 02/13/2025 | 8,000 | $139,360 | 0.00% | 0.01% |
Bicara Therapeutics Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 77 institutional investors and hedge funds held shares of Bicara Therapeutics Inc. Common Stock. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 6.96 M
Siren, L.L.C.: 3.27 M
TPG GP A, LLC: 3.01 M
Omega Fund Management, LLC: 2.2 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.18 M
FMR LLC: 2.12 M
85.26% of Bicara Therapeutics Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 39.09 M shares in the last 24 months. This purchase volume represents approximately $395.96 M in transactions.